ArticlePharmaceutics2024

The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.

Xavier J H Pepin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.